Jarrell Rayner
Family Medicine · Indianapolis, INNPI 1902434814
Payments from drug & device makers
Across 70 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$203
- AbbVie$179
- Amgen$133
- Novartis$103
- Novo Nordisk$87
- AstraZeneca$82
- plus $578 from 16 others
What the payments were for
- Food & beverage$1,365100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 14 | $203 |
| AbbVie | 6 | $179 |
| Amgen | 7 | $133 |
| Novartis | 4 | $103 |
| Novo Nordisk | 5 | $87 |
| AstraZeneca | 5 | $82 |
| Johnson & Johnson | 4 | $64 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $62 |
| GSK | 3 | $60 |
| Edwards Lifesciences | 1 | $53 |
| Exact Sciences | 2 | $43 |
| Dexcom, Inc. | 2 | $41 |
| Bayer | 2 | $40 |
| Pfizer | 2 | $38 |
| Exeltis, USA Inc. | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Lundbeck LLC | 1 | $21 |
| Corium, LLC | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $16 |
| Merck | 1 | $14 |
How this compares
$1,365 in reported general payments places this provider in the 65th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spiriva RespimatTiotropium Bromide | 11 | $5,937 |
| Omeprazole | 19 | $678 |
| Rosuvastatin Calcium | 38 | $344 |
| Metformin Hcl | 21 | $254 |
| Atorvastatin Calcium | 34 | $247 |
| Levothyroxine Sodium | 21 | $220 |
| Lisinopril | 14 | $170 |
| Trazodone Hcl | 18 | $146 |
| Tamsulosin Hcl | 12 | $119 |
| Gabapentin | 11 | $107 |
| Simvastatin | 11 | $69 |
| Losartan Potassium | 12 | $66 |
| Amlodipine Besylate | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Indianapolis
- Blair BrengleIndianapolis$10.6M
- Steven SmithIndianapolis$2.5M
- Richard TannerIndianapolis$1.6M
- Richard FeldmanIndianapolis$476K
- Joe BanksIndianapolis$294K
- Jakoda SniderIndianapolis$107K
- Robert ClutterIndianapolis$77K
- Gaylen KeltonIndianapolis$42K
- Daniela LoboIndianapolis$38K
- Haihong MaoIndianapolis$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.